Literature DB >> 22179216

Bacterial load and degree of gastric mucosal inflammation in Helicobacter pylori infection.

M Varbanova1, P Malfertheiner.   

Abstract

Helicobacter pylori induces an inflammatory immune response in the gastric mucosa. The degree of gastric mucosal inflammation and its topographic distribution are key factors in the diversity of H. pylori-related complications. Here we summarize substantial evidence reported in the literature concerning the impact of H. pylori density on gastric inflammation, the development of severe complications, and its relation to H. pylori suppression therapy. Most studies demonstrate a significant correlation between H. pylori density and the grade of acute and chronic inflammation, taking into account the limitations of each method for density assessment. Overall, high bacterial loads are associated with increased acute mucosal damage and long-term changes in the gastric mucosa. The influence of H. pylori density reduction on the improvement of gastric mucosal changes was observed in studies using 'clearance' therapies. Mucosal agents provoke a significant, but not persistent, reduction in gastritis activity. Treatments suppressing the density and virulence of H. pylori could become strategies to prevent H. pylori-associated disease in the future.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22179216     DOI: 10.1159/000333260

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  6 in total

1.  CagA and VacA genotypes in peptic ulcer disease and non-ulcer dyspepsia: a case-control study.

Authors:  Hashem FakhreYaseri; Mehdi Shakaraby; Hamid Reza Bradaran; Seyed Kamran Soltani Arabshahi; Ali Mohammad Fakhre Yaseri
Journal:  Med J Islam Repub Iran       Date:  2014-09-28

2.  Usefulness of a Helicobacter pylori stool antigen test for diagnosing H. pylori infected C57BL/6 mice.

Authors:  Dae-In Moon; Eun-Hye Shin; Hong-Geun Oh; Jin-Sik Oh; Sunhwa Hong; Yungho Chung; Okjin Kim
Journal:  Lab Anim Res       Date:  2013-03-25

3.  Significant Reduction in Helicobacter pylori Load in Humans with Non-viable Lactobacillus reuteri DSM17648: A Pilot Study.

Authors:  Caterina Holz; Andreas Busjahn; Heidrun Mehling; Stefanie Arya; Mewes Boettner; Hajar Habibi; Christine Lang
Journal:  Probiotics Antimicrob Proteins       Date:  2015-06       Impact factor: 4.609

4.  Multiscale positive feedbacks contribute to unidirectional gastric disease progression induced by helicobacter pylori infection.

Authors:  Richard Ballweg; Frederick Schozer; Kelsey Elliott; Alexander Kuhn; Logan Spotts; Eitaro Aihara; Tongli Zhang
Journal:  BMC Syst Biol       Date:  2017-11-22

5.  The effect of Lactobacillus reuteri supplementation in Helicobacter pylori infection: a placebo-controlled, single-blind study.

Authors:  Martin Buckley; Sean Lacey; Andrea Doolan; Emily Goodbody; Kelly Seamans
Journal:  BMC Nutr       Date:  2018-12-07

6.  Contribution of genetic amplification by PCR for the diagnosis of Helicobacter pylori infection in patients receiving proton pump inhibitors.

Authors:  Thomas Bazin; Arouna Nchare Mfondi; Catherine Julie; Jean-François Émile; Josette Raymond; Dominique Lamarque
Journal:  United European Gastroenterol J       Date:  2018-06-27       Impact factor: 4.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.